Access cutting-edge high cholesterol treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access high cholesterol specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related high cholesterol treatment provided free
This is a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in children (aged 2 to \<12 years) with homozygous familial hypercholesterolemia (HoFH) and elevated low density lipoprotein cholesterol (LDLC).
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this high cholesterol clinical trial in San Francisco, CA
If you're searching for high cholesterol treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced high cholesterol specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.